Clozapine-induced cardiac failure.

Area of Science:

• Geriatric Medicine
• Psychopharmacology
• Cardiology

Background:

• Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia and other psychotic disorders.
• Elderly patients often have comorbidities and altered pharmacokinetics, increasing susceptibility to adverse drug reactions.
• Cardiac complications are a known, albeit rare, side effect of clozapine therapy.

Purpose of the Study:

• To report a case of cardiac failure in an elderly patient treated with clozapine.
• To emphasize the potential cardiotoxicity of clozapine in the geriatric population.
• To highlight the importance of cautious prescribing and monitoring of clozapine in elderly individuals.

Main Methods:

• Case report of a 73-year-old female patient with dementia and treatment-resistant psychotic symptoms.
• Administration of clozapine for psychotic symptom management.
• Observation and documentation of subsequent cardiac failure.

Main Results:

• The patient developed cardiac failure following initiation of clozapine therapy.
• The adverse event occurred in an elderly patient with a history of dementia.

Conclusions:

• Clozapine treatment, even in elderly patients with dementia, carries a risk of serious cardiac adverse events.
• Healthcare providers should exercise caution and consider close cardiac monitoring when prescribing clozapine to geriatric patients.
• This case underscores the need for individualized risk-benefit assessments in elderly patients initiating clozapine.